Company Overview and News

2
Jaypee Infratech Limited - News Clarification

2018-06-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
533207 JPINFRATEC

2
Jaypee Infratech Limited - News Clarification

2018-06-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
533207 JPINFRATEC

3
Hope to recover Rs 2,000 crore from NPA resolution in FY#39;19, says IFCI

2018-06-17 moneycontrol
Saddled with bad loans, the country's oldest financial institution IFCI expects to recover about Rs 2,000 crore from the resolution of non-performing assets (NPAs) during the current fiscal. The state-owned term lender has also lined up some of its non-core fixed assets including commercial real estate for sale in 2018-19 provided they fetch good value, IFCI Managing Director ES Rao told PTI.
ESL 513250 AMKD JYOTISTRUC BHUSANSTL AMTEKAUTO 533264 532778 530323 ABGSHIP 533207 532682 JPINFRATEC 521070 ALOKTEXT ERAINFRA LITL 520077 500055

21
Jaiprakash Associates to submit plan to protect home buyers’ interest in Supreme Court

2018-06-15 freepressjournal.in
New Delhi: Crisis-hit Jaypee group flagship firm Jaiprakash Associates Ltd (JAL) will submit an appropriate proposal before the Supreme Court to protect the interest of its stuck home buyers.
UBNC 500116 AXB JIPKY IBN IDBI JPASSOCIAT 532525 532215 MAHABANK 532532 AXBKY 532179 SYNDIBANK AXBA ICICIBANK 533207 532276 JPINFRATEC CRPKY AXISBANK 532174 CORPBANK

3
FSDC panel discusses insolvency resolution process

2018-06-14 moneycontrol
Amidst mounting bad loans, the FSDC sub-committee headed by RBI Governor Urjit Patel today reviewed the insolvency resolution process under the Insolvency and Bankruptcy Code (IBC), the Reserve Bank said. Besides, the Financial Stability and Development Council-sub committee also reviewed major developments on the global and domestic fronts that impinge on the financial stability of the country, the RBI said in a statement.
ESL 513250 AMKD JYOTISTRUC BHUSANSTL AMTEKAUTO 533264 532778 530323 ABGSHIP 533207 532682 JPINFRATEC 521070 ALOKTEXT ERAINFRA LITL 520077 500055

2
India’s Right to Throw Homebuyers a Lifeline - Bloomberg

2018-06-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
533207 JPINFRATEC

5
BSE brings 109 firms under enhanced surveillance

2018-06-04 moneycontrol
Leading stock exchange BSE today decided to bring 109 companies, including Reliance Naval and Engineering, Amtek Auto, GVK Power & Infrastructure under enhanced surveillance measures. "...100 percent margins shall be applicable with effect from June 6, 2018 on all open positions as on June 5, 2018 and new positions created from June 6, 2018 onwards," the exchange said in a circular.
532960 AMKD RAIN 533207 JPINFRATEC IBVENTURES 500339 AMTEKAUTO 520077 IDBLZ 532775 GTLINFRA

22
NCLAT admits Jaiprakash Associates’ plea over returning Jaypee Infratech’s 759 acres land

2018-05-31 livemint
New Delhi: The National Company Law Appellate Tribunal (NCLAT) on Thursday admitted an appeal by Jaiprakash Associates Ltd (JAL) challenging an order passed by National Company Law Tribunal’s (NCLT) Allahabad bench directing it to return 759 acres of land to its subsidiary Jaypee Infratech Ltd (JIL).
500116 AXB JIPKY IBN IDBI JPASSOCIAT 532215 532532 AXBKY AXBA ICICIBANK 533207 JPINFRATEC AXISBANK 532174 SBAZ

21
Jaypee Infra’s 700-acre land to remain with banks for now

2018-05-25 freepressjournal.in
New Delhi : The National Company Law Appellate Tribunal on Thursday admitted an appeal moved by ICICI Bank, Axis Bank and others challenging an order passed by the Allahabad bench of the National Company Law Tribunal directing Jaiprakash Associates to return over 700 acres of land to its subsidiary Jaypee Infratech.
500116 AXB JIPKY IBN IDBI JPASSOCIAT 532215 532532 AXBKY AXBA ICICIBANK 533207 JPINFRATEC AXISBANK 532174

43
Closing Bell: Sensex up over 300 pts, midcaps underperform; IT zooms, ONGC dips

2018-05-25 moneycontrol
Benchmark indices rose, driven by IT stocks, such as, Infosys and TCS on the back of a weak rupee. The IT index has gained 18 percent so far this year. The rupee has weakened by more than 7 percent so far this year, as surging crude oil prices weigh on India, the world’s third-largest importer, raising fears that soaring costs could drive up inflation and widen the trade deficit.
500325 JIPKY MS.PRE MS.PRF 531548 MS.PRG MS.PRA 534976 533207 AJANTPHARM BJJQY MS 500570 RLNIY AXB 524804 JETAIRWAYS 531335 AXBA BAJFINANCE MS.PRI FORTIS MS.PRK SOMANYCERA AUROPHARMA RELIANCE 532617 533155 BHRQY JUBLFOOD 532215 AXISBANK RIGD JBLWY BHARTIARTL 505324 TATAMOTORS MANUGRAPH 500034 IBN JPASSOCIAT 532843 AXBKY 532532 532454 VMART ICICIBANK 532331 JPINFRATEC 532174 ARBQY ZYDUSWELL TTM

34
NCLAT admits lenders’ plea over surrender of Jaypee land

2018-05-25 livemint
New Delhi: The National Company Law Appellate Tribunal (NCLAT) on Thursday admitted an appeal moved by ICICI Bank Ltd and other lenders challenging an order passed by National Company Law Tribunal’s (NCLT) Allahabad bench directing Jaiprakash Associates Ltd (JAL) to return 759 acres of land to its unit Jaypee Infratech Ltd (JIL).
STAN 500116 AXB JIPKY IBN IDBI JPASSOCIAT 532215 532532 AXBKY AXBA ICICIBANK 533207 JPINFRATEC 580001 STAB AXISBANK 532174 STAN STAC 2888 SCBFF SBAZ

2
IBC: Govt tosses a new lifeline to homebuyers

2018-05-23 livemint
New Delhi: The Union cabinet on Wednesday approved an ordinance to amend the Insolvency and Bankruptcy Code (IBC) 2016 to put homebuyers on par with financial creditors when deciding the fate of real estate firms that have defaulted on loan payments.
533207 JPINFRATEC

7
NSE issues show-cause notice to UB Holdings, 15 others for delisting of shares

2018-05-23 thehindubusinessline
Leading stock exchange NSE has issued a show-cause notice to defaulter businessman Vijay Mallya-led UB (Holdings) for delisting of its shares as trading has been suspended for a long time due to regulatory non-compliance.
ESL AMKD REIAGROLTD BRFL 532715 AMTEKAUTO 531723 532678 IDBLZ GITANJALI 532960 REISIXTEN 533207 REAA SGJHL SBAZ TALWALKARS 533180 NEPCMICON IBVENTURES REA 533065 533264 533200 532106 532765 USHERAGRO GTJLY ORFR JPINFRATEC 500301 STAMPEDE 520077

3
Jaiprakash Associates plunges 29.5%, the most in nearly 3 years

2018-05-21 thehindubusinessline
Shares of infrastructure company Jaiprakash Associates Ltd slumped as much as 29.51 per cent in their biggest percentage loss since June 2015.
521248 500008 JIPKY JPASSOCIAT 532538 UCLQF ULTRACEMCO ARJQY AMARAJABAT 532532 533207 JPINFRATEC UCLQY KITEX

2
Jaiprakash Associates to challenge NCLT order

2018-05-21 freepressjournal.in
New Delhi : Crisis-ridden Jaiprakash Associates (JAL) has decided to appeal against the NCLT order that directed the company to return nearly 760 acre land to its subsidiary Jaypee Infratech, while declaring the transfer of the land as “fraudulent” and “undervalued”.
532532 533207 JPINFRATEC JIPKY JPASSOCIAT

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

1h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...